title: Apixaban in atrial fibrillation: does predicted risk matter?
authors.affiliation: Papworth Hospital, Cambridge University Health Partners, Papworth Everard, Cambridge CB23 8RE, UK. vassiliou@doctors.org.uk
authors.forename: Vassilis S
authors.initials: VS
authors.lastname: Vassiliou
authors.forename: Paul D
authors.initials: PD
authors.lastname: Flynn
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D014859:Warfarin